Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis

The development of a new vaccine as a substitute for Bacillus Calmette–Guerin or to improve its efficacy is one of the many World Health Organization goals to control tuberculosis. Mycobacterial vectors have been used successfully in the development of vaccines against tuberculosis. To enhance the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Junqueira-Kipnis, Ana Paula, de Oliveira, Fábio Muniz, Trentini, Monalisa Martins, Tiwari, Sangeeta, Chen, Bing, Resende, Danilo Pires, Silva, Bruna D. S., Chen, Mei, Tesfa, Lydia, Jacobs, William R., Kipnis, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826754/
https://www.ncbi.nlm.nih.gov/pubmed/24250805
http://dx.doi.org/10.1371/journal.pone.0078639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826754/
https://www.ncbi.nlm.nih.gov/pubmed/24250805
http://dx.doi.org/10.1371/journal.pone.0078639

Ejemplares similares